Related Experiment Video
Updated: Oct 6, 2025

09:49
A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
10.1K
A mobile high-resolution gamma camera for therapeutic dose control during radionuclide therapy
Carlotta Trigila1, Marc-Antoine Verdier1,2, Laurent Pinot1
1Université Paris-Saclay, CNRS/IN2P3, IJCLab, F-91405 Orsay, France.
Physics in Medicine and Biology
|January 17, 2022
Summary
A new mobile gamma camera improves iodine-131 (131I) dosimetry for thyroid cancer treatment. This bedside tool enhances quantitative assessment, optimizing patient radiation therapy doses for better clinical outcomes.
Area of Science:
- Nuclear Medicine
- Medical Imaging
- Radiotherapy Physics
Background:
- Molecular radiotherapy using iodine-131 (131I) is a primary treatment for thyroid diseases.
- Significant patient variability in therapeutic doses and treatment effects necessitates individualized dosimetry.
- Accurate quantitative assessment of 131I distribution and biokinetics is crucial for optimizing clinical outcomes.
Purpose of the Study:
- To develop a high-resolution, mobile gamma camera for bedside quantitative assessment of 131I.
- To evaluate the imaging performance and quantification capabilities of the prototype camera.
- To validate the camera's utility for individualized dosimetry in thyroid disease treatment.
Main Methods:
- Developed a prototype mobile gamma camera with a 5 × 5 cm2 field of view, featuring a 3D-printed tungsten collimator and a CeBr3 scintillator with silicon photomultiplier detectors.
- Evaluated intrinsic and overall imaging performance using 133Ba and 131I sources.
- Tested quantification accuracy with 131I-filled thyroid phantoms using single and conjugate view approaches, with and without scatter correction.
Main Results:
- The camera demonstrated high imaging performance: 7.68 ± 0.01% energy resolution, 0.74 ± 0.28 mm intrinsic spatial resolution, and 0.15 ± 0.10 mm spatial distortion.
- Overall spatial resolution was 3.14 ± 0.03 mm at 5 cm with a sensitivity of 1.23 ± 0.01 cps/MBq.
- Activity recovery factors exceeding 97% were achieved with thyroid phantoms, indicating excellent quantification accuracy.
Conclusions:
- The developed mobile gamma camera shows significant promise for accurate 131I quantification at the patient's bedside.
- Preliminary results support its potential as a tool for individualized dosimetry in molecular radiotherapy for thyroid diseases.
- Further development is motivated towards a clinical-grade camera with enhanced imaging capabilities and a larger field of view.

